Intrinsic Value of S&P & Nasdaq Contact Us

Axcella Health Inc. AXLA NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
42/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$60.00
+1210%

Financial Health Score — AXLA

Axcella Health Inc. (AXLA) has an overall financial health rating of C+ with a composite score of 0 out of 5.

This suggests the company faces some financial challenges worth monitoring. Rating as of 2023-12-29.

C+
Overall Rating
2023-12-29

Rating History

Date Rating DCF ROE ROA D/E P/E P/B
2023-12-29 C+ -/5 -/5 -/5 -/5 -/5 -/5
2023-12-28 B+ -/5 -/5 -/5 -/5 -/5 -/5
2023-12-27 B+ -/5 -/5 -/5 -/5 -/5 -/5
2023-12-26 B+ -/5 -/5 -/5 -/5 -/5 -/5
2023-12-22 B+ -/5 -/5 -/5 -/5 -/5 -/5
2023-12-21 B+ -/5 -/5 -/5 -/5 -/5 -/5
2023-12-20 B+ -/5 -/5 -/5 -/5 -/5 -/5
2023-12-19 B+ -/5 -/5 -/5 -/5 -/5 -/5
2023-12-18 B+ -/5 -/5 -/5 -/5 -/5 -/5
2023-12-15 B+ -/5 -/5 -/5 -/5 -/5 -/5
2023-12-14 B+ -/5 -/5 -/5 -/5 -/5 -/5
2023-12-13 B+ -/5 -/5 -/5 -/5 -/5 -/5
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message